Good morning :)
Omkar Pharmachem Ltd

Omkar Pharmachem Ltd

OMKARPH Share Price

BSE
29.500.00% (+0.00)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹29 cr, stock is ranked 4,137

Stock is 3.32x as volatile as Nifty

OMKARPH Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Bad

The stock is in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

With a market cap of ₹29 cr, stock is ranked 4,137

Stock is 3.32x as volatile as Nifty

OMKARPH Performance & Key Metrics

OMKARPH Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
299.923.18
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
27.633.161.63%

OMKARPH Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

OMKARPH Company Profile

Omkart works in ares related to pharmaceuticals, chemicals and to provide management and business support services.

OMKARPH Similar Stocks (Peers)

Compare with peers Compare with peers 

OMKARPH Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
106.63
106.63
1Y Return
41.14%
41.14%
Buy Reco %
88.89
88.89
LINDEINDIA
PE Ratio
130.21
130.21
1Y Return
15.34%
15.34%
Buy Reco %
50.00
50.00
PE Ratio
39.85
39.85
1Y Return
9.28%
9.28%
Buy Reco %
0.00
0.00
PE Ratio
28.33
28.33
1Y Return
25.67%
25.67%
Buy Reco %
50.00
50.00
PE Ratio
37.65
37.65
1Y Return
21.61%
21.61%
Buy Reco %
85.71
85.71
Compare with Peers

OMKARPH Forecast

OMKARPH Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

OMKARPH

OMKARPH

Income

Balance Sheet

Cash Flow

OMKARPH Income Statement

OMKARPH Income Statement

Loading...

Quartersep 2023dec 2023mar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025
Total Revenue0.140.140.140.140.140.140.140.140.140.11
Operating & Other expensessubtract0.040.070.060.090.050.050.070.100.070.06
Depreciation/Amortizationsubtract0.000.000.000.000.000.000.000.000.000.00
Interest & Other Itemssubtract0.000.000.030.000.000.000.020.000.000.00
Taxes & Other Itemssubtract0.000.000.060.000.000.000.070.010.020.01
EPS0.090.07-0.020.050.090.08-0.020.030.050.03

OMKARPH Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual report

PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

OMKARPH Stock Peers

OMKARPH Past Performance & Peer Comparison

OMKARPH Past Performance & Peer Comparison

Comparing 3 stocks from 
MaterialsCommodity Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Omkar Pharmachem Ltd157.853.18
Solar Industries India Ltd106.6328.340.07%
Linde India Ltd130.2115.500.17%
Himadri Speciality Chemical Ltd39.855.870.13%

OMKARPH Stock Price Comparison

Compare OMKARPH with any stock or ETF
Compare OMKARPH with any stock or ETF
OMKARPH
Loading...

OMKARPH Holdings

OMKARPH Shareholdings

OMKARPH Promoter Holdings Trend

OMKARPH Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

OMKARPH Institutional Holdings Trend

OMKARPH Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

OMKARPH Shareholding Pattern

OMKARPH Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding0.03%0.00%0.00%0.00%99.97%

Mar 2025

Jun 2025

Sep 2025

Dec 2025

OMKARPH Shareholding History

OMKARPH Shareholding History

SepDec '24MarJunSepDec '250.00%0.00%0.00%0.00%0.00%0.00%

OMKARPH Insider Trades & Bulk Stock Deals

OMKARPH Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing OMKARPH stock

smallcases containing OMKARPH stock

Looks like this stock is not in any smallcase yet.

OMKARPH Events

OMKARPH Events

OMKARPH Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

OMKARPH has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

OMKARPH Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

OMKARPH has not given any dividends in last 5 years

OMKARPH Dividends

OMKARPH Dividends

Hmm, looks like data is unavailable here. Please come back after some time

OMKARPH Stock News & Opinions

OMKARPH Stock News & Opinions

Earnings
Omkar Pharmachem standalone net profit declines 62.50% in the December 2025 quarter

Net profit of Omkar Pharmachem declined 62.50% to Rs 0.03 crore in the quarter ended December 2025 as against Rs 0.08 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Omkar Pharmachem to table results

Omkar Pharmachem will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Omkar Pharmachem standalone net profit declines 44.44% in the September 2025 quarter

Net profit of Omkar Pharmachem declined 44.44% to Rs 0.05 crore in the quarter ended September 2025 as against Rs 0.09 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Omkar Pharmachem to table results

Omkar Pharmachem will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Omkar Pharmachem to hold AGM

Omkar Pharmachem announced that the 30th Annual General Meeting(AGM) of the company will be held on 24 September 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
Omkar Pharmachem standalone net profit declines 40.00% in the June 2025 quarter

Net profit of Omkar Pharmachem declined 40.00% to Rs 0.03 crore in the quarter ended June 2025 as against Rs 0.05 crore during the previous quarter ended June 2024. There were no Sales reported in the quarter ended June 2025 and during the previous quarter ended June 2024.Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Omkar Pharmachem to announce Quarterly Result

Omkar Pharmachem will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Omkar Pharmachem reports standalone net loss of Rs 0.02 crore in the March 2025 quarter

Net Loss of Omkar Pharmachem reported to Rs 0.02 crore in the quarter ended March 2025 as against net loss of Rs 0.02 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024. For the full year,net profit rose 5.26% to Rs 0.20 crore in the year ended March 2025 as against Rs 0.19 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
Omkar Pharmachem to convene board meeting

Omkar Pharmachem will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live

9 months agoCapital Market - Live
Earnings
Omkar Pharmachem standalone net profit rises 14.29% in the December 2024 quarter

Net profit of Omkar Pharmachem rose 14.29% to Rs 0.08 crore in the quarter ended December 2024 as against Rs 0.07 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live

1 year agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Omkar Pharmachem Ltd (OMKARPH) today?

    The share price of OMKARPH as on 16th February 2026 is ₹29.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Omkar Pharmachem Ltd (OMKARPH) share?

    The past returns of Omkar Pharmachem Ltd (OMKARPH) share are
    • Past 1 week: N/A%
    • Past 1 month: N/A%
    • Past 3 months: 4.13%
    • Past 6 months: 14.88%
    • Past 1 year: -1.67%
    • Past 3 years: 23.43%
    • Past 5 years: 49.75%

  3. What are the peers or stocks similar to Omkar Pharmachem Ltd (OMKARPH)?
  4. What is the market cap of Omkar Pharmachem Ltd (OMKARPH) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Omkar Pharmachem Ltd (OMKARPH) is ₹29.99 Cr as of 16th February 2026.

  5. What is the 52 week high and low of Omkar Pharmachem Ltd (OMKARPH) share?

    The 52-week high of Omkar Pharmachem Ltd (OMKARPH) is ₹30.09 and the 52-week low is ₹25.50.

  6. What is the PE and PB ratio of Omkar Pharmachem Ltd (OMKARPH) stock?

    The P/E (price-to-earnings) ratio of Omkar Pharmachem Ltd (OMKARPH) is 157.85. The P/B (price-to-book) ratio is 3.18.

  7. Which sector does Omkar Pharmachem Ltd (OMKARPH) belong to?

    Omkar Pharmachem Ltd (OMKARPH) belongs to the Materials sector & Commodity Chemicals sub-sector.

  8. How to buy Omkar Pharmachem Ltd (OMKARPH) shares?

    You can directly buy Omkar Pharmachem Ltd (OMKARPH) shares on Tickertape. Simply sign up, connect your demat account and place your order.